MCM
IPXL

Matarin Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Matarin Capital Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-75,473
Closed -$3.54M – 212
2015
Q1 		$3.54M Buy
75,473
+22,541
+43% +$897K 1.07% 14
2014
Q4 		$1.68M Hold
52,932
– – 0.74% 62
2014
Q3 		$1.26M Sell
52,932
-25,360
-32% -$650K 0.58% 79
2014
Q2 		$2.35M Buy
78,292
+14,375
+22% +$388K 1.05% 13
2014
Q1 		$1.69M Sell
63,917
-8,876
-12% -$222K 1% 29
2013
Q4 		$1.83M Buy
72,793
+29,819
+69% +$665K 1.13% 36
2013
Q3 		$880K Buy
42,974
+6,503
+18% +$134K 0.74% 59
2013
Q2 		$727K Buy
+36,471
New +$647K 0.73% 50

Other funds holding IPXL

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
HP
Hound Partners New York $792M AUM 9.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AG
Aravt Global New York $11.3M AUM 3.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return